Current management of infected aortic grafts in patients with connective tissue disorders
Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of inf...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Glebova, Natalia O. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function - Shukla, Ankur J. ELSEVIER, 2014, New York, NY |
|---|---|
| Übergeordnetes Werk: |
volume:30 ; year:2017 ; number:2 ; pages:75-79 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1053/j.semvascsurg.2017.10.003 |
|---|
| Katalog-ID: |
ELV041384504 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041384504 | ||
| 003 | DE-627 | ||
| 005 | 20230624084628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.semvascsurg.2017.10.003 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000065A.pica |
| 035 | |a (DE-627)ELV041384504 | ||
| 035 | |a (ELSEVIER)S0895-7967(17)30048-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 540 |a 530 |q VZ |
| 084 | |a ASIEN |q DE-1a |2 fid | ||
| 084 | |a 6,25 |2 ssgn | ||
| 084 | |a 35.90 |2 bkl | ||
| 084 | |a 33.61 |2 bkl | ||
| 084 | |a 51.00 |2 bkl | ||
| 100 | 1 | |a Glebova, Natalia O. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current management of infected aortic grafts in patients with connective tissue disorders |
| 264 | 1 | |c 2017 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. | ||
| 700 | 1 | |a Black, James H. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Shukla, Ankur J. ELSEVIER |t Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |d 2014 |g New York, NY |w (DE-627)ELV017907071 |
| 773 | 1 | 8 | |g volume:30 |g year:2017 |g number:2 |g pages:75-79 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1053/j.semvascsurg.2017.10.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-ASIEN | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_26 | ||
| 912 | |a GBV_ILN_70 | ||
| 936 | b | k | |a 35.90 |j Festkörperchemie |q VZ |
| 936 | b | k | |a 33.61 |j Festkörperphysik |q VZ |
| 936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 30 |j 2017 |e 2 |h 75-79 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
n o g no nog |
|---|---|
| matchkey_str |
glebovanataliaoblackjamesh:2017----:urnmngmnoifcearigatiptetwtcn |
| hierarchy_sort_str |
2017 |
| bklnumber |
35.90 33.61 51.00 |
| publishDate |
2017 |
| allfields |
10.1053/j.semvascsurg.2017.10.003 doi GBV00000000000065A.pica (DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Glebova, Natalia O. verfasserin aut Current management of infected aortic grafts in patients with connective tissue disorders 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. Black, James H. oth Enthalten in Elsevier Shukla, Ankur J. ELSEVIER Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function 2014 New York, NY (DE-627)ELV017907071 volume:30 year:2017 number:2 pages:75-79 extent:5 https://doi.org/10.1053/j.semvascsurg.2017.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 30 2017 2 75-79 5 045F 610 |
| spelling |
10.1053/j.semvascsurg.2017.10.003 doi GBV00000000000065A.pica (DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Glebova, Natalia O. verfasserin aut Current management of infected aortic grafts in patients with connective tissue disorders 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. Black, James H. oth Enthalten in Elsevier Shukla, Ankur J. ELSEVIER Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function 2014 New York, NY (DE-627)ELV017907071 volume:30 year:2017 number:2 pages:75-79 extent:5 https://doi.org/10.1053/j.semvascsurg.2017.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 30 2017 2 75-79 5 045F 610 |
| allfields_unstemmed |
10.1053/j.semvascsurg.2017.10.003 doi GBV00000000000065A.pica (DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Glebova, Natalia O. verfasserin aut Current management of infected aortic grafts in patients with connective tissue disorders 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. Black, James H. oth Enthalten in Elsevier Shukla, Ankur J. ELSEVIER Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function 2014 New York, NY (DE-627)ELV017907071 volume:30 year:2017 number:2 pages:75-79 extent:5 https://doi.org/10.1053/j.semvascsurg.2017.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 30 2017 2 75-79 5 045F 610 |
| allfieldsGer |
10.1053/j.semvascsurg.2017.10.003 doi GBV00000000000065A.pica (DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Glebova, Natalia O. verfasserin aut Current management of infected aortic grafts in patients with connective tissue disorders 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. Black, James H. oth Enthalten in Elsevier Shukla, Ankur J. ELSEVIER Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function 2014 New York, NY (DE-627)ELV017907071 volume:30 year:2017 number:2 pages:75-79 extent:5 https://doi.org/10.1053/j.semvascsurg.2017.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 30 2017 2 75-79 5 045F 610 |
| allfieldsSound |
10.1053/j.semvascsurg.2017.10.003 doi GBV00000000000065A.pica (DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Glebova, Natalia O. verfasserin aut Current management of infected aortic grafts in patients with connective tissue disorders 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. Black, James H. oth Enthalten in Elsevier Shukla, Ankur J. ELSEVIER Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function 2014 New York, NY (DE-627)ELV017907071 volume:30 year:2017 number:2 pages:75-79 extent:5 https://doi.org/10.1053/j.semvascsurg.2017.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 35.90 Festkörperchemie VZ 33.61 Festkörperphysik VZ 51.00 Werkstoffkunde: Allgemeines VZ AR 30 2017 2 75-79 5 045F 610 |
| language |
English |
| source |
Enthalten in Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function New York, NY volume:30 year:2017 number:2 pages:75-79 extent:5 |
| sourceStr |
Enthalten in Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function New York, NY volume:30 year:2017 number:2 pages:75-79 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Festkörperchemie Festkörperphysik Werkstoffkunde: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |
| authorswithroles_txt_mv |
Glebova, Natalia O. @@aut@@ Black, James H. @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV017907071 |
| dewey-sort |
3610 |
| id |
ELV041384504 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041384504</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624084628.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.semvascsurg.2017.10.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000065A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041384504</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0895-7967(17)30048-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ASIEN</subfield><subfield code="q">DE-1a</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">6,25</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Glebova, Natalia O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current management of infected aortic grafts in patients with connective tissue disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Black, James H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Shukla, Ankur J. ELSEVIER</subfield><subfield code="t">Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function</subfield><subfield code="d">2014</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV017907071</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:30</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:75-79</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.semvascsurg.2017.10.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-ASIEN</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.90</subfield><subfield code="j">Festkörperchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.61</subfield><subfield code="j">Festkörperphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">30</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">75-79</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Glebova, Natalia O. |
| spellingShingle |
Glebova, Natalia O. ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 Current management of infected aortic grafts in patients with connective tissue disorders |
| authorStr |
Glebova, Natalia O. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV017907071 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences 530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl Current management of infected aortic grafts in patients with connective tissue disorders |
| topic |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 |
| topic_unstemmed |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 |
| topic_browse |
ddc 610 ddc 540 fid ASIEN ssgn 6,25 bkl 35.90 bkl 33.61 bkl 51.00 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j h b jh jhb |
| hierarchy_parent_title |
Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |
| hierarchy_parent_id |
ELV017907071 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry 530 - Physics |
| hierarchy_top_title |
Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV017907071 |
| title |
Current management of infected aortic grafts in patients with connective tissue disorders |
| ctrlnum |
(DE-627)ELV041384504 (ELSEVIER)S0895-7967(17)30048-0 |
| title_full |
Current management of infected aortic grafts in patients with connective tissue disorders |
| author_sort |
Glebova, Natalia O. |
| journal |
Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |
| journalStr |
Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
75 |
| author_browse |
Glebova, Natalia O. |
| container_volume |
30 |
| physical |
5 |
| class |
610 610 DE-600 610 VZ 540 530 VZ ASIEN DE-1a fid 6,25 ssgn 35.90 bkl 33.61 bkl 51.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Glebova, Natalia O. |
| doi_str_mv |
10.1053/j.semvascsurg.2017.10.003 |
| dewey-full |
610 540 530 |
| title_sort |
current management of infected aortic grafts in patients with connective tissue disorders |
| title_auth |
Current management of infected aortic grafts in patients with connective tissue disorders |
| abstract |
Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. |
| abstractGer |
Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. |
| abstract_unstemmed |
Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-ASIEN SSG-OLC-PHA GBV_ILN_26 GBV_ILN_70 |
| container_issue |
2 |
| title_short |
Current management of infected aortic grafts in patients with connective tissue disorders |
| url |
https://doi.org/10.1053/j.semvascsurg.2017.10.003 |
| remote_bool |
true |
| author2 |
Black, James H. |
| author2Str |
Black, James H. |
| ppnlink |
ELV017907071 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1053/j.semvascsurg.2017.10.003 |
| up_date |
2024-07-06T19:58:21.734Z |
| _version_ |
1803860995456630784 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041384504</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624084628.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.semvascsurg.2017.10.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000065A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041384504</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0895-7967(17)30048-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">ASIEN</subfield><subfield code="q">DE-1a</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">6,25</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Glebova, Natalia O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current management of infected aortic grafts in patients with connective tissue disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Black, James H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Shukla, Ankur J. ELSEVIER</subfield><subfield code="t">Xanthine Oxidoreductase as an Oxygen Sensor in Endothelial Function</subfield><subfield code="d">2014</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV017907071</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:30</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:75-79</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.semvascsurg.2017.10.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-ASIEN</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.90</subfield><subfield code="j">Festkörperchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.61</subfield><subfield code="j">Festkörperphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">30</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">75-79</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400591 |